ATG9A and cancer: To determine whether the genetic invalidation of ATG9A expression also led to an inhibition of cancer-associated phenotypes, similar to the ones already observed in the sh-ATG9A clones, we quantified the proliferation rate of these cells using a MTT assay (Figure 4C).